Marcos Leite Santoro

Marcos Leite Santoro

Auto-generated profile, based on publicly available information

Marcos Leite Santoro

Post-Graduation Program in Structural and Functional Biology, Universidade Federal de São Paulo, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
EAElizabeth G. Atkinson
Elizabeth G. Atkinson
AMAdam X. Maihofer
Adam X. Maihofer
MKMasahiro Kanai
Masahiro Kanai
AMALICIA MARTIN
ALICIA MARTIN
KKKonrad J. Karczewski
Konrad J. Karczewski
BNBenjamin M. Neale
Benjamin M. Neale

18 April 2024 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
CNCaroline Nievergelt
Caroline Nievergelt
AMAdam X. Maihofer
Adam X. Maihofer
EAElizabeth G. Atkinson
Elizabeth G. Atkinson
CCChia-Yen Chen
Chia-Yen Chen
KCKarmel W. Choi
Karmel W. Choi
KKKarestan C. Koenen
Karestan C. Koenen

5 April 2022 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
RBRachel M. Brouwer
Rachel M. Brouwer
MKMarieke Klein
Marieke Klein
KGKatrina Grasby
Katrina Grasby
HSHugo G. Schnack
Hugo G. Schnack
NJNeda Jahanshad
Neda Jahanshad
HPHilleke E. Hulshoff Pol
Hilleke E. Hulshoff Pol

8 February 2021 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
SLSophie E. Legge
Sophie E. Legge
MSMarcos L. Santoro
Marcos L. Santoro
SPSathish Periyasamy
Sathish Periyasamy
AOAdeniran Okewole
Adeniran Okewole
AAArsalan Arsalan
Arsalan Arsalan
KKKaarina Kowalec
Kaarina Kowalec
Schizophrenia is a severe psychiatric disorder with high heritability. Consortia efforts and technological advancements have led to a substantial increase in knowledge of the genetic architecture of schizophrenia over the past decade. In this article, we provide an overview of the current understanding of the genetics of schizophrenia, outline remaining challenges, and summarise future directions of research. World-wide collaborations have resulted in genome-wide association studies (GWAS) in over 56 000 schizophrenia cases and 78 000 controls, which identified 176 distinct genetic loci. The latest GWAS from the Psychiatric Genetics Consortium, available as a pre-print, indicates that 270 distinct common genetic loci have now been associated with schizophrenia. Polygenic risk scores can currently explain around 7.7% of the variance in schizophrenia case-control status. Rare variant studies have implicated eight rare copy-number variants, and an increased burden of loss-of-function variants in SETD1A, as increasing the risk of schizophrenia. The latest exome sequencing study, available as a pre-print, implicates a burden of rare coding variants in a further nine genes. Gene-set analyses have demonstrated significant enrichment of both common and rare genetic variants associated with schizophrenia in synaptic pathways. To address current challenges, future genetic studies of schizophrenia need increased sample sizes from more diverse populations. Continued expansion of international collaboration will likely identify new genetic regions, improve fine-mapping to identify causal variants, and increase our understanding of the biology and mechanisms of schizophrenia.

1 June 2018 in American Journal of Psychiatry
Verified
Journal Article
Closed access
LALuiza K. Axelrud
Luiza K. Axelrud
MSMarcos L. Santoro
Marcos L. Santoro
DPDaniel S. Pine
Daniel S. Pine
FTFernanda Talarico
Fernanda Talarico
AGAry Gadelha
Ary Gadelha
GSGiovanni A. Salum
Giovanni A. Salum

6 February 2023 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
JHJessica Honorato-Mauer
Jessica Honorato-Mauer
GXGabriela Xavier
Gabriela Xavier
VOVanessa Kiyomi Ota
Vanessa Kiyomi Ota
SCSamar Nasser Chehimi
Samar Nasser Chehimi
FMFernanda Mafra
Fernanda Mafra
MSMarcos Leite Santoro
Marcos Leite Santoro
Extracellular vesicles (EVs) are present in numerous peripheral bodily fluids and function in critical biological processes, including cell-to-cell communication. Most relevant to the present study, EVs contain microRNAs (miRNAs), and initial evidence from the field indicates that miRNAs detected in circulating EVs have been previously associated with mental health disorders. Here, we conducted an exploratory longitudinal and cross-sectional analysis of miRNA expression in serum EVs from adolescent participants. We analyzed data from a larger ongoing cohort study, evaluating 116 adolescent participants at two time points (wave 1 and wave 2) separated by three years. Two separate data analyses were employed: A cross-sectional analysis compared individuals diagnosed with Major Depressive Disorder (MDD), Anxiety disorders (ANX) and Attention deficit/Hyperactivity disorder (ADHD) with individuals without psychiatric diagnosis at each time point. A longitudinal analysis assessed changes in miRNA expression over time between four groups showing different diagnostic trajectories (persistent diagnosis, first incidence, remitted and typically developing/control). Total EVs were isolated, characterized by size distribution and membrane proteins, and miRNAs were isolated and sequenced. We then selected differentially expressed miRNAs for target prediction and pathway enrichment analysis. In the longitudinal analysis, we did not observe any statistically significant results. In the cross-sectional analysis: in the ADHD group, we observed an upregulation of miR-328-3p at wave 1 only; in the MDD group, we observed a downregulation of miR-4433b-5p, miR-584-5p, miR-625-3p, miR-432-5p and miR-409-3p at wave 2 only; and in the ANX group, we observed a downregulation of miR-432-5p, miR-151a-5p and miR-584-5p in ANX cases at wave 2 only. Our results identified previously observed and novel differentially expressed miRNAs and their relationship with three mental health disorders. These data are consistent with the notion that these miRNAs might regulate the expression of genes associated with these traits in genome-wide association studies. The findings support the promise of continued identification of miRNAs contained within peripheral EVs as biomarkers for mental health disorders.